edoc

Items where Author is "Harris, Stephanie A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2019 | 2018 | 2016 | 2015 | 2014
Number of items: 7.

2019

Manjaly Thomas, Zita-Rose and Satti, Iman and Marshall, Julia L. and Harris, Stephanie A. and Lopez Ramon, Raquel and Hamidi, Ali and Minhinnick, Alice and Riste, Michael and Stockdale, Lisa and Lawrie, Alison M. and Vermaak, Samantha and Wilkie, Morven and Bettinson, Henry and McShane, Helen. (2019) Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial. PLoS Medicine, 16 (4). e1002790.

Müller, Julius and Tanner, Rachel and Matsumiya, Magali and Snowden, Margaret A. and Landry, Bernard and Satti, Iman and Harris, Stephanie A. and O'Shea, Matthew K. and Stockdale, Lisa and Marsay, Leanne and Chomka, Agnieszka and Harrington-Kandt, Rachel and Manjaly Thomas, Zita-Rose and Naranbhai, Vivek and Stylianou, Elena and Mbandi, Stanley Kimbung and Hatherill, Mark and Hussey, Gregory and Mahomed, Hassan and Tameris, Michele and McClain, J. Bruce and Evans, Thomas G. and Hanekom, Willem A. and Scriba, Thomas J. and McShane, Helen and Fletcher, Helen A.. (2019) Cytomegalovirus infection is a risk factor for tuberculosis disease in infants. JCI insight, 4 (23). e130090.

2018

Harris, Stephanie A. and White, Andrew and Stockdale, Lisa and Tanner, Rachel and Sibley, Laura and Sarfas, Charlotte and Meyer, Joel and Peter, Jonathan and O'Shea, Matthew K. and Manjaly Thomas, Zita-Rose and Hamidi, Ali and Satti, Iman and Dennis, Mike J. and McShane, Helen and Sharpe, Sally. (2018) Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines. Tuberculosis, 108. pp. 99-105.

2016

Fletcher, Helen A. and Snowden, Margaret A. and Landry, Bernard and Rida, Wasima and Satti, Iman and Harris, Stephanie A. and Matsumiya, Magali and Tanner, Rachel and O'Shea, Matthew K. and Dheenadhayalan, Veerabadran and Bogardus, Leah and Stockdale, Lisa and Marsay, Leanne and Chomka, Agnieszka and Harrington-Kandt, Rachel and Manjaly Thomas, Zita-Rose and Naranbhai, Vivek and Stylianou, Elena and Darboe, Fatoumatta and Penn-Nicholson, Adam and Nemes, Elisa and Hatherill, Mark and Hussey, Gregory and Mahomed, Hassan and Tameris, Michele and McClain, J. Bruce and Evans, Thomas G. and Hanekom, Willem A. and Scriba, Thomas J. and McShane, Helen. (2016) T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nature Communications, 7. p. 11290.

2015

Sheehan, Sharon and Harris, Stephanie A. and Satti, Iman and Hokey, David A. and Dheenadhayalan, Veerabadran and Stockdale, Lisa and Manjaly Thomas, Zita-Rose and Minhinnick, Alice and Wilkie, Morven and Vermaak, Samantha and Meyer, Joel and O'Shea, Matthew K. and Pau, Maria Grazia and Versteege, Isabella and Douoguih, Macaya and Hendriks, Jenny and Sadoff, Jerald and Landry, Bernard and Moss, Paul and McShane, Helen. (2015) A phase I, open-label trial, evaluating the safety and immunogenicity of candidate tuberculosis vaccines AERAS-402 and MVA85A, administered by prime-boost regime in BCG-vaccinated healthy adults. PloS One, 10 (11). e0141687.

2014

Harris, Stephanie A. and Satti, Iman and Matsumiya, Magali and Stockdale, Lisa and Chomka, Agnieszka and Tanner, Rachel and O'Shea, Matthew K. and Manjaly Thomas, Zita-Rose and Tameris, Michele and Mahomed, Hassan and Scriba, Thomas J. and Hanekom, Willem A. and Fletcher, Helen A. and McShane, Helen. (2014) Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A. Clinical and vaccine immunology, 21 (7). pp. 1005-1011.

Satti, Iman and Meyer, Joel and Harris, Stephanie A. and Manjaly Thomas, Zita-Rose and Griffiths, Kristin and Antrobus, Richard D. and Rowland, Rosalind and Ramon, Raquel Lopez and Smith, Mary and Sheehan, Sharon and Bettinson, Henry and McShane, Helen. (2014) Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infectious Diseases, 14 (10). pp. 939-946.

This list was generated on Sat Nov 28 15:32:29 2020 CET.